Drug Shortage Report for SODIUM BICARBONATE INJECTION, USP
| Report ID | 186632 |
| Drug Identification Number | 02486628 |
| Brand name | SODIUM BICARBONATE INJECTION, USP |
| Common or Proper name | SODIUM BICARBONATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | SODIUM BICARBONATE |
| Strength(s) | 42MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 5 mL |
| ATC code | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2024-03-08 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-04-05 |
| Company comments | Fresenius Kabi Canada regrets to advise that the limited supply of Sodium Bicarbonate Injection, USP 4.2% 2.5 mEq (mmol) Vial 5 mL brought in to support the shortage in the Canadian market has been depleted effective March 8, 2024. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2024-04-05 | French | Compare |
| v4 | 2024-04-05 | English | Compare |
| v3 | 2023-03-10 | French | Compare |
| v2 | 2023-03-10 | English | Compare |
| v1 | 2023-03-10 | English | Compare |
Showing 1 to 5 of 5